![Eric N. Shiozaki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric N. Shiozaki
Directeur/Membre du Conseil chez
Unlearn.AI, Inc.
Profil
Eric N.
Shiozaki is currently Director at Unlearn.
AI, Inc., Partner at DCVC Management Co. LLC since 2021, and Partner at Revelation Partners LLC starting in 2024.
Formerly, Dr. Shiozaki was Director at PROCEPT BioRobotics Corp., Director at Apposite Capital LLP from 2011 to 2014, Director of Corporate Development & Strategy at VitaPath Genetics, Inc. in 2009, Associate at Burrill LLC from 2007 to 2009, and Partner at Novo Ventures (US), Inc. from 2018 to 2021.
Dr. Shiozaki completed undergraduate studies at The Johns Hopkins University in 1999 and earned a doctorate from Princeton University in 2003.
Postes actifs de Eric N. Shiozaki
| Sociétés | Poste | Début |
|---|---|---|
DCVC Management Co. LLC
 DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Private Equity Investor | 01/06/2021 |
Unlearn.AI, Inc.
 Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine | Directeur/Membre du Conseil | - |
Revelation Partners LLC
 Revelation Partners LLC Investment ManagersFinance Revelation Partners invests in companies located in the United States with a minimum revenues of USD 20 million. The firm focuses on medical devices, biopharmaceuticals, diagnostics & life science tools, consumer health and healthcare IT & services. It participates in early and growth stage capital transactions with an investment size of USD 5 - 50 million. The firm also makes follow on investments. | Private Equity Investor | 01/12/2024 |
Anciens postes connus de Eric N. Shiozaki
| Sociétés | Poste | Fin |
|---|---|---|
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Private Equity Investor | 01/06/2021 |
Apposite Capital LLP
 Apposite Capital LLP Investment ManagersFinance Apposite Capital invests in companies located in the United Kingdom and European with revenues of up to EUR 100 million. The firm focuses on the technology sector. It provides financing for MBOs, buy-ins and growth capital requirements. It also acquires minority interest. | Analyste en capital-investissement | 31/05/2014 |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Analyste en capital-investissement | 31/12/2009 |
VitaPath Genetics, Inc.
 VitaPath Genetics, Inc. Medical/Nursing ServicesHealth Services Develops molecular diagnostics | Directeur/Membre du Conseil | 31/07/2009 |
| PROCEPT BIOROBOTICS CORPORATION | Directeur/Membre du Conseil | - |
Formation de Eric N. Shiozaki
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
PROCEPT BioRobotics Corp.
 PROCEPT BioRobotics Corp. Medical SpecialtiesHealth Technology Develops robotic therapy systems for the treatment of lower urinary tract symptoms | Health Technology |
Burrill LLC
Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apposite Capital LLP
Apposite Capital LLP Investment ManagersFinance Apposite Capital invests in companies located in the United Kingdom and European with revenues of up to EUR 100 million. The firm focuses on the technology sector. It provides financing for MBOs, buy-ins and growth capital requirements. It also acquires minority interest. | Finance |
VitaPath Genetics, Inc.
VitaPath Genetics, Inc. Medical/Nursing ServicesHealth Services Develops molecular diagnostics | Health Services |
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Finance |
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Finance |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine | Technology Services |
Revelation Partners LLC
Revelation Partners LLC Investment ManagersFinance Revelation Partners invests in companies located in the United States with a minimum revenues of USD 20 million. The firm focuses on medical devices, biopharmaceuticals, diagnostics & life science tools, consumer health and healthcare IT & services. It participates in early and growth stage capital transactions with an investment size of USD 5 - 50 million. The firm also makes follow on investments. | Finance |
Choisissez Zonebourse 
